SEC Comment Letter 0000000000-23-009100 to Tengjun Biotechnology Corp. (CIK 0001499785)
Tengjun Biotechnology Corp. (CIK 0001499785)
Date: Aug. 21, 2023 · CIK: 0001499785 · Accession: 0000000000-23-009100
AI Filing Summary & Sentiment
File numbers found in text: 333-169397
Show Raw Text
United States securities and exchange commission logo
August 21, 2023
Xianchang Ma
Chief Executive Officer and Chief Financial Officer
Tengjun Biotechnology Corp.
East Jinze Road and South Huimin Road
Food Industry Economic and Technology Development District
Jianxiang County , Jining City
Shandong Province, China
Re:Tengjun Biotechnology Corp.
Form 8-K filed August 14, 2023
File No. 333-169397
Dear Xianchang Ma:
We have reviewed your filing and have the following comment. In our comment, we
may ask you to provide us with information so we may better understand your disclosure.
Please respond to this comment within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this comment, we may have additional comments.
Form 8-K filed August 14, 2023
Item 4.02 - Non-reliance on Previously Issued Financial Statements or a Related Audit Report or
Completed Interim Review
1.Please amend your report to include all of the information required by Item 4.02(a) of
Form 8-K, including disclosure of the following information:
•a brief description of the facts underlying your conclusion of non-reliance on your
previously issued financial statements to the extent known to you at the time of filing;
and
•a statement of whether the audit committee, or the board of directors in the absence
of an audit committee, or authorized officer or officers, discussed with your
independent accountant the matters disclosed in the filing pursuant to this Item
4.02(a).
FirstName LastNameXianchang Ma
Comapany NameTengjun Biotechnology Corp.
August 21, 2023 Page 2
FirstName LastName
Xianchang Ma
Tengjun Biotechnology Corp.
August 21, 2023
Page 2
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
You may contact SiSi Cheng at 202-551-5004 or Ernest Greene at 202-551-3733 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing